APPLICATION
ANDA206398
TYPE
ANDA
ORIGINAL APPROVAL
2016-03-23
LATEST ACTION
2025-07-09
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
VORICONAZOLEDiscontinued
VORICONAZOLE 200MG/VIAL · POWDER · INTRAVENOUS
Approval history
2025-07-09Labeling · Supplement 8 · standardAP
2023-02-02Labeling · Supplement 7 · standardAP
2023-02-02Labeling · Supplement 6 · standardAP
2021-07-02Labeling · Supplement 5 · standardAP
2021-07-02Labeling · Supplement 1 · standardAP
2016-03-23UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.